International Biotechnology (LON:IBT) Insider Buys £10,695 in Stock

International Biotechnology (LON:IBT) insider Katherine Cornish-Bowden purchased 1,500 shares of the firm’s stock in a transaction dated Tuesday, December 17th. The shares were bought at an average cost of GBX 713 ($8.91) per share, with a total value of £10,695 ($13,367.08).

International Biotechnology Trading Down 4.8 %

LON IBT opened at GBX 674 ($8.42) on Friday. The company has a market capitalization of £249.11 million, a price-to-earnings ratio of 1,404.17 and a beta of 0.21. The company has a debt-to-equity ratio of 9.66, a current ratio of 0.46 and a quick ratio of 0.32. International Biotechnology has a 12 month low of GBX 588 ($7.35) and a 12 month high of GBX 734 ($9.17). The company’s fifty day moving average price is GBX 695.11 and its two-hundred day moving average price is GBX 678.36.

International Biotechnology Increases Dividend

The business also recently declared a dividend, which will be paid on Friday, January 24th. Stockholders of record on Thursday, December 19th will be given a dividend of GBX 15.56 ($0.19) per share. This is a boost from International Biotechnology’s previous dividend of $14.50. The ex-dividend date of this dividend is Thursday, December 19th. This represents a dividend yield of 2.21%. International Biotechnology’s dividend payout ratio (DPR) is presently 6,041.67%.

International Biotechnology Company Profile

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.